Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor

European Journal of Clinical Investigation

Volumn 40, Issue 6, 2010, Pages 561-565

  Sturm, Brigitte ^a   Helminger, Melissa ^a   Steinkellner, Hannes ^a   Heidari, Mohammad Mehdi ^a,b   Goldenberg, Hans ^a   Scheiber Mojdehkar, Barbara ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b YAZD UNIVERSITY   (Iran)

Author keywords

Carbamylated erythropoietin; Erythropoietin receptor; Frataxin; Friedreich's ataxia; Nonerythropoietic erythropoietin; Recombinant human erythropoietin

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; FRATAXIN; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; CARBAMOYLATION; CELL STRAIN K 562; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; ELECTROCHEMICAL ANALYSIS; FRIEDREICH ATAXIA; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; MONOCYTIC LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; FRIEDREICH ATAXIA; HUMANS; IRON-BINDING PROTEINS; K562 CELLS; LYMPHOCYTES; MACROPHAGES; RECOMBINANT PROTEINS;

EID: 77952611229     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02292.x     Document Type: Article

References (17)

1. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996 271: 1423 1427.
2. Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S. Frataxin is reduced in Friedreich's ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 1997 6: 1771 1780.
3. Napier I, Ponka P, Richardson DR. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 2005 105: 1867 1874.
4. Zhang Y, Lyver ER, Knight SAB, Lesuisse E, Dancis A. Frataxin and mitochondrial carrier proteins, Mrs3p and Mrs4p, cooperate in providing iron for heme synthesis. J Biol Chem 2005 280: 19794 19807.
5. Bradley JL, Blake JC, Chamberlain S, Thomas PK, Cooper JM, Schapira AHV. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Gen 2000 9: 275 282.
6. Bulteau AL, O'Neill HA, Kennedy MC, Ikeda-Saito M, Isaya G, Szweda LI. Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 2004 305: 242 244.
7. Sturm B, Stupphann D, Kaun C, Boesch S, Schranzhofer M, Wojta J et al. Recombinant human erythropoietin: effects on frataxin expression in vitro. Eur J Clin Invest 2005 35: 711 717.
8. Boesch S, Sturm B, Hering S, Poewe W, Goldenberg H, Scheiber-Mojdehkar B. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Ann Neurol 2007 62: 521 524.
9. Boesch S, Sturm B, Hering S, Scheiber-Mojdehkar B, Steinkellner H, Goldenberg H et al. Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial. Mov Disord 2008 23: 1940 1944.
10. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004 305: 239 242.
11. Lapchak PA, Kirkeby A, Zivin JA, Sager TN. Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits. Brain Res 2008 1238: 208 214.
12. Imamura R, Okumi M, Isaka Y, Ichimaru N, Moriyama T, Imai E et al. Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injury. Cell Transplant 2008 17: 135 141.
13. Fiordaliso F, Chimenti S, Staszewsky L, Bai A, Carlo E, Cuccovillo I et al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci USA 2005 102: 2046 2051.
14. Villa P, van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A et al. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab 2007 27: 552 563.
15. Sanchez PE, Navarro FP, Fares RP, Nadam J, Georges B, Moulin C et al. Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span. J Comp Neurol 2009 514: 403 414.
16. Steinkellner H, Scheiber-Mojdehkar B, Goldenberg H, Sturm B. A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels. Anal Chim Acta 2010 659: 129 132.
17. Gupta M, Miller BA, Ahsan N, Ulsh PJ, Zhang MY, Cheung JY et al. Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis. Transplantation 2000 70: 1188 1194.